Synaptogenix, Inc. (SNPX) Financials

SNPX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 32.4 million 3.9 million
2023-06-30 33.4 million 6.5 million
2023-03-31 36.5 million 2.3 million
2022-12-31 38.6 million 3.2 million

SNPX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.2 million 15064
2023-06-30 -1.2 million 334416
2023-03-31 -1.7 million 644781
2022-12-31 -2.8 million 1.5 million

SNPX Net Income

No data available :(

SNPX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 31.7 million - -
2023-06-30 32.9 million - -
2023-03-31 35.8 million - -
2022-12-31 37.5 million - -

SNPX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 10.7 million
2023-06-30 7.4 million
2023-03-31 7.5 million
2022-12-31 7.0 million

SNPX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 212103 1.2 million -
2023-06-30 669 307211 1.5 million -
2023-03-31 2038 877717 2.0 million -
2022-12-31 2139 1.4 million 4.5 million -

SNPX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1723
2023-06-30 - 1724
2023-03-31 - 1690
2022-12-31 - 1526

SNPX

Price: $4.53

52 week price:
3.53
47.00

Earnings Per Share: -29.50 USD

P/E Ratio: -0.19

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1967

Market Capitalization: 5.0 million

Links: